Surveillance of methicillin-resistant Staphylococcus aureus (MRSA) and Enterobacteriaceae producing extended-spectrum β-lactamase (ESBLE) in Northern France:: a five-year multicentre incidence study

被引:63
作者
Albertini, MT [1 ]
Astagneau, P [1 ]
Benoit, C [1 ]
Berardi, L [1 ]
Berrouane, Y [1 ]
Boisivon, A [1 ]
Cahen, P [1 ]
Cattoen, C [1 ]
Costa, Y [1 ]
Darchis, P [1 ]
Delière, E [1 ]
Demontrond, D [1 ]
Eb, F [1 ]
Golliot, F [1 ]
Grise, G [1 ]
Harel, A [1 ]
Koeck, JL [1 ]
Lepennec, MP [1 ]
Malbrunot, C [1 ]
Marcollin, M [1 ]
Maugat, S [1 ]
Nouvellon, M [1 ]
Pangon, B [1 ]
Ricouart, S [1 ]
Roussel-Delvallez, M [1 ]
Vachée, A [1 ]
Carbonne, A [1 ]
Marty, L [1 ]
Jarlier, V [1 ]
机构
[1] C CLIN Nord, Inst Cordeliers, F-75006 Paris, France
关键词
antibiotic resistance; epidemiology; prevention; surveillance; nosocomial;
D O I
10.1053/jhin.2002.1286
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
In order to measure the incidence of methicillin-resistant Staphylococcus aureus (MRSA) and of Enterobacteriaceae producing extended-spectrum beta-lactamase (ESBLE), and to evaluate the impact of the national guidelines for multidrug-resistant bacteria (MDRB) prevention in hospitals of Northern France, a multicentre survey was conducted for three months every year starting in 1996, in volunteer hospital laboratories. All clinical specimens positive for MRSA and ESBLE were prospectively surveyed. During the five-year surveillance period, the overall proportion of MRSA was 38.4% in the 28 534 strains of S. aureus, and that of ESBLE was 11.4% in the 6121 strains of Klebsiella pneumoniae and 47.7% in the 2353 strains of Enterobacter aerogenes. The overall incidence rates of clinical specimens positive for MRSA, ESBL-K. pneumoniae and E. aerogenes were 0.84, 0.05 and 0.12/1000 hospital-days (HD), respectively. In the 23 hospitals that participated in the survey every year, the proportion and incidence of MRSA increased from 35.6 to 41.0% and from 0.71 to 0.96/1000 HD (P < 0.001). Conversely, the incidence of ESBLE decreased. Hence, despite recommendations as for isolation precautions, MRSA remains poorly controlled and requires more effective measures. (C) 2002 The Hospital Infection Society.
引用
收藏
页码:107 / 113
页数:7
相关论文
共 35 条
[31]   CONTROL OF EPIDEMIC METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS IN A DUTCH UNIVERSITY HOSPITAL [J].
VANDENBROUCKEGRAULS, CM ;
FRENAY, HME ;
VANKLINGEREN, B ;
SAVELKOUL, TF ;
VERHOEF, J .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1991, 10 (01) :6-11
[32]  
VERBIST L, 1991, SCAND J INFECT DIS, P45
[33]   METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS IN EUROPE [J].
VOSS, A ;
MILATOVIC, D ;
WALLRAUCHSCHWARZ, C ;
ROSDAHL, VT ;
BRAVENY, I .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 (01) :50-55
[34]   COST OF NOSOCOMIAL INFECTION - RELATIVE CONTRIBUTIONS OF LABORATORY, ANTIBIOTIC, AND PER DIEM COSTS IN SERIOUS STAPHYLOCOCCUS-AUREUS INFECTIONS [J].
WAKEFIELD, DS ;
HELMS, CM ;
MASSANARI, RM ;
MORI, M ;
PFALLER, M .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (05) :185-192
[35]   Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas and the Western Pacific region [J].
Winokur, PL ;
Canton, R ;
Casellas, JM ;
Legakis, N .
CLINICAL INFECTIOUS DISEASES, 2001, 32 :S94-S103